The use of kisspeptin and neurokinin B suppressive therapies may be used to treat CPP, and the use of kisspeptin and neurokinin B stimulating therapies may be used to restore the menstrual cyclicity in women with HA. This evidence concerns the gene TAC3 and central precocious puberty.